Analysis of K-ras gene mutations in lung carcinomas: Correlation with gender, histological subtypes, and clinical outcome

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 9, 1998, Pages 517-522

  Wang, Yi Ching ^a   Lee, Hong Shen ^a   Chen, Shin Kuang ^a   Yang, Sen Chih ^a   Chen, Chih Yi ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Taichung General Veterans Hospital   (Taiwan)

Author keywords

Adenocarcinoma; K ras oncogene; Lung cancer; Mutation spectrum; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENDER; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; PRIORITY JOURNAL; TAIWAN; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUTORADIOGRAPHY; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEX FACTORS; SURVIVAL ANALYSIS; TAIWAN;

EID: 0031669403     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050208     Document Type: Article

References (28)

1. Cho JY, Kim JH, Lee YH, Chung KY, Kim SK, Gong SJ, You NC, Chung HC, Roh JK, Kim BS (1997) Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. Cancer 79:462-467
2. Dalley BK, Cannon JF (1996) Novel, activated ras mutations alter protein-protein interactions. Oncogene 13:1209-1220
3. Denissenko MF, Pao A, Tang MS, Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274:430-432
4. Department of Health, The Executive Yuan, Republic of China (1996) General health statistics. In: Health and vital statistics. Republic of China. R. O. C. Press, Taipei, pp 88-111
5. Fukuyama Y, Mitsudomi T, Sugio K, Ishida T, Akazawa K, Sugimachi K (1997) K-ras and p53 mutations are an independent unfavorable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer 75:1125-1130
6. Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T (1997) Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis 18:473-478
7. Giaccone G (1996) Oncogenes and antioncogenes in lung tumori-genesis. Chest 105[Suppl]:130s-134s
8. Husgafvel-Prusiainen K, Hackman P, Ridanpaa M, Anttila S, Karjalainen A, Partanen T, Taikina-Aho O, Heikkila L, Vaino H (1993) K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int J Cancer 53:250-256
9. Isobe T, Hiyama K, Yoshida Y, Kujiwara Y, Michio Y (1994) Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection. Jpn J Cancer Res 85:1240-1246
10. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457-481
11. Kashii T, Mizushima Y, Lima CEQ, Noto H, Sato H, Saito H, Kusajima Y, Kitagawa M, Yamaoto K, Kobayashi M (1995) Studies on clincopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups. Oncolgy 52:219-225
12. Keohavong P, Thilly WG (1992) Mutational spectrometry: a general approach for hotspot point mutations in selectable genes. Proc Natl Acad Sci USA 89:4623-4627
13. Keohavong P, DeMichele MAA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM (1996) Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res 2:411-418
14. Kitagawa Y, Wong F, Patrick L, Elliott M, Verburgt LM, Hogg JC, Daya M (1996) Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers. Am J Respir Cell Mol Biol 15:45-54
15. Koo LC, Ho JH (1990) Worldwide epidemiological patterns of lung cancer in nonsmokers. Int J Epidemiol 19:S13-S14
16. Lee ET (1992) Statistical methods for survival data analysis, 2nd edn. J Wiley, New York, pp 1-7
17. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI, Harris CC (1991) p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51:4090-4096
18. Lung ML, Wong M, Lam WK, Lau KS, Kwan S, Fu KH, Cheung H, Yew WW (1992) Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 70:760-763
19. Matzinger SA, Crist KA, Stoner GD, Anderson MW, Pereira MA, Steele VE, Kelloff GJ, Lubet RA, You M (1995) K-ras mutations in lung tumors from A/J and A/J × TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 16:2487-2492
20. Rodenhuis S, Slebos RJ (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52[Suppl]:2665s-2669s
21. Slebos RJC, Hruban RH, Dalesio O, Mooi WJ, Olfenhaus GJA, Rodenhuis S (1991) Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst 83:1024-1027
22. Suigo K, Ishida T, Tokoyama H, Inoue T, Sugimachi K, Sasazuki T (1992) ras gene mutation as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 52:2903-2906
23. Törmänen VT, Pfeifer GP (1992) Mapping of UV photoproducts within ras protooncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene 7:1729-1736
24. The Lifetest Procedure (1988) Additional SAS/STAT procedures. Release 6.03. SAS Technical Report: P-179. SAS Institute, Cary, NC, pp 49-90
25. Travis WD, Lubin J, Ries L, Devesa S (1996) United States lung carcinoma incidence trends. Cancer 77: 2464-2470
26. Vachtenheim J, Horakova I, Novotna H, Opalka P, Roubkova H (1995) Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Clin Cancer Res 1:359-365
27. Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H (1998) High frequency of deletion mutations in p53 gene from squamous-cell lung cancer patients in Taiwan. Cancer Res 58:328-333
28. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW (1989) Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86:3070-3074